1. Glutamine synthetase activity has been determined in extracts of rat cardiac and skeletal muscle and kidney, after treatment to ensure that the rate of synthesis was proportional to time of incubation and to amount of extract added. The activity was measured by two methods, with hydroxylamine as substrate. 2. No activity was detected in rat heart extract by either method. The activity in skeletal muscle was of the order of 20,umol of glutamylhydroxamate synthesized/h per g of tissue under optimum conditions. The activity in kidney extracts was 180,mol/h per g of tissue when measured as ferric hydroxamate. 3. The activity in both skeletal-muscle and kidney extracts was inhibited by Pi. The inhibition is competitive for the muscle enzyme, with a KL of 12mM. For the kidney enzyme the inhibition is non-competitive, and less marked. Possible enzyme mechanisms that would lead to these types of inhibition are discussed. 4. Several observations are reported that suggest that the enzymes from muscle and kidney are not identical.
5. Growth hormone, either in vivo or in vitro, did not affect the measured glutamine synthetase activity of tissue extracts.
Glutamine is one of the amino acids whose concentration is highest both intracellularly and in the blood plasma of vertebrates. In rat plasma its concentration is about 0.55mM (Herbert, Coulson & Hernandez, 1966) which is higher than that of any other amino acid. In tissues its concentration is about 2.5[tmol/g of wet tissue, although it is much higher in liver, heart and brain. Kidney forms an exception to this general rule, since the concentration of glutamine in this tissue is only 0.3,umol/g, which is lower than that of many other amino acids.
In spite of this detailed information about the distribution of glutamine in the body, remarkably little is known about its function, except as a source of NH4+ in acid-base control by the kidney, and as a direct source of -NH2 groups for the synthesis of some non-protein nitrogenous compounds, particularly purines. In many tissues of the body, however, purine nucleotide synthesis must proceed at a very slow rate, and it seems rather doubtful that such very high concentrations of glutamine are necessary to support these particular syntheses. It is widely supposed that glutamine is a detoxication product of ammonia (e.g. Cantarow & Schepartz, 1967) , and that, by implication, the glutamine found in plasma is on its way from peripheral tissues to liver or kidney so that the -NH2 group may be finally removed from the body as urea, uric acid, or NH4+ ions in urine. Experimental infusion of NH4+ ion into blood has been shown to lead to a fall in glutamate concentration and a rise in glutamine (Takagaki, Berl, Clarke, Purpura & Waelsch, 1961) , and this may well be a detoxication process. However, in certain circumstances muscle is capable of forming ammonia at a rapid rate [e.g. from the deamination of AMP (Parnas, 1935) ], but it has never been clearly established that either skeletal or cardiac muscle can synthesize glutamine at all. Only two detailed reports on the synthesis of glutamine in these tissues in mammals have appeared (Trush, 1963; Wu, 1963) . The former reported low levels of glutamine synthetase activity in both heart and skeletal muscle, but the experimental methods used were not above criticism, and the results cannot be accepted with complete confidence. Wu (1963) did not find any glutamine synthetase in cardiac or skeletal muscle of the rat. It was decided to reinvestigate this problem, to help answer the question of whether the muscle mass is one of the sources of plasma glutamine, or whether muscle takes up glutamine from the plasma for a function that has not yet been established. Because we are interested in the relationship between pituitary growth hormone and nitrogen metabolism, some experiments on the concentration of glutamine synthetase in tissues after growth-hormone injections were also carried out and are reported here.
To establish beyond doubt the reliability and limits of accuracy of the assay methods, it was thought desirable to include measurements on extracts of a tissue in which it has been well established that glutamine synthetase is present. Extensive studies have been carried out on the glutamine synthetase of brain, liver, retina and kidney (for reviews see Meister, 1965 Meister, , 1968 . We found that kidney was a satisfactory source of the enzyme (Reiner & Hudson, 1953; Richterich & Goldstein, 1958) for comparative purposes, although some evidence accumulated that the enzymes from muscle and kidney are not identical, at least in the rat.
METHODS
Two assay methods were used. One was based on the determination of the y-glutamylhydroxamate formed when hydroxylamine is used as a substrate. The concentration of the hydroxamate may be measured by the extinction of its complex with Fe3+ ions. The sensitivity of the colour reaction was doubled by using Fe(NO3)3 in trichloroacetic acid instead of the FeCl3 in HCI used by Lipmann & Tuttle (1945) . We found that the nitrate gave a slightly more intense colour, and was less likely to give a high tissue blank, than the perchlorate in HCI04 recommended by Goddu, LeBlanc & Wright (1955 Elliott's (1955) finding that the amount of hydroxamate produced is proportional to the amount of extract added (except as described below).
The reaction was stopped by adding 2ml of ferric reagent [consisting of equal volumes of 40% (w/v) trichloroacetic acid and of 0.6n-Fe(NO3)3,9H20]. After being rapidly mixed and allowed to stand for about 1Omin, the precipitated protein was removed by centrifuging in a bench centrifuge for about 10min, and the extinction of the supernatant was measured at BOOnm. The concentration of y-glutamylhydroxamate was determined from a calibration curve prepared from a sample of the pure substance [Sigma (London) Chemical Co. Ltd., London S.W.6, U.K.].
The method described above is reliable and convenient, but is not very sensitive, and has the major disadvantage that ADP, which is a powerful inhibitor of the enzyme, can accumulate from side reactions during the incubation, and may prevent the maximum activity from being measured. To overcome this difficulty a method based on coupling the production of ADP, as the reaction proceeds, to the oxidation of NADH, by adding pyruvate kinase, phosphoenolpyruvate and lactate dehydrogenase to the system, was developed. The method described below allows a correction to be made for the activity of other ADP-producing reactions (adenosine triphosphatases) in the tissue extract; with muscle extracts these are often much more active than glutamine synthetase. Similar methods designed for use with purified glutamine synthetase have been published by Wellner, Zoukis & Meister (1966) , Kingdon, Hubbard & Stadtman (1968) , and Liess, Varricchio, Mecke & Holzer (1968) .
The The volume at this stage was 0.8 ml. When the lactate dehydrogenase, pyruvate kinase and adenylate kinase mixture was added, there was a rapid, though limited, decrease in E340 as ADP and AMP in the reagents were removed. The mixture was left for 3-5min until the E340 trace was steady, and at this point 0.2 ml of tissue extract, suitably diluted with water, was added to the cuvette and rapidly mixed. The decrease in E340 was followed for about 3min; it was generally linear over this period. All measurements were made at 37°C.
Correction for adenosine triphosphatase activity could be made by running a parallel assay from which glutamate was omitted, but when measurements were being made at various ATP concentrations it was found to be more convenient to record the adenosine triphosphatase activity on the same sample. This was done by omitting the glutamate from the original reaction mixture, recording the decrease in E340 after the addition of tissue extract, and at a suitable time adding 50,umol of L-glutamate (usually in 0.1 ml), and continuing to record the extinction change. It was necessary to make a correction for the change in concentration of both ATP and adenosine triphosphatase after adding the glutamate.
ADP was measured by the method of Adam (1963) , and
Pi by the method of Taussky & Shorr (1953) .
Preparation of ti88ue extract8. This was based on the method of Trush (1963) . The tissues were removed from a rat immediately after death and transferred into ice-cold 0.15M-NaCI-5mM-NaHCO3. The tissue samples were washed with an excess of this solution, blotted, weighed and then frozen at -20°C (for a minimum period of 45 min). After being thawed, the tissue samples were chopped with scissors and homogenized in ice-cold NaCl-NaHCO3, (5 ml/g of tissue). A Potter-Elvehjem homogenizer with a Teflon pestle was used for heart and kidney, and an Ultra-Turrax (Janke und Kunkel K.G., Staufen i. Br., Germany) for skeletal muscle. About 2.5g of muscle from the leg of each animal was used. The homogenate was left at 2°C for about 2 h, with frequent shaking, for extraction of the enzyme to reach completion.
As described in the Results section, the activity in the homogenates was increased by centrifuging the homogenate at 56000g for 45min in the type 40 rotor of a Spinco preparative ultracentrifuge at 20C. The supernatant was filtered through four layers of muslin to remove fat particles, and was then dialysed against 2 x lOOvol. of 0.15M-NaCI-5mM-NaHCO3, containing 1mM-EDTA and 5mM-mercaptoethanol, for a total of 3 h at about 5°C. When the activity was to be assayed by the NADH method, a KCl-KHCO3 solution of the same ionic strength was used. The dialysed supernatant was stored in the cold and used on the day of preparation, although it was possible to keep the frozen tissue samples at -20°C for up to 48 h without significant loss of activity.
In some instances interference by the adenosine triphosphatases of the centrifuged homogenates was removed by precipitating the glutamine synthetase with solid (NH4)2SO4 (Enzyme grade; BDH Chemicals Ltd., Poole, Dorset, U.K.). The precipitate was left for about 15min before being spun down on a bench centrifuge. The precipitate was redissolved in a small volume of KCI-KHCO3 solution and dialysed as described above.
All chemicals used were AnalaR grade or the equivalent. Pi was recrystallized by adding the calculated quantity of 40% (w/v) NaOH to a hot concentrated solution of NaH2PO4 containing 5mM-EDTA, and allowing the solution to cool. The crystals were filtered off, washed with ethanol and dried in a desiccator. They were found by analysis to consist of Na2HPO4,2 H20. Enzymes were obtained from Boehringer und Soehne G.m.b.H., Mannheim, Germany.
Bovine pituitary growth hormone, lot NIH GH-Bll, stated potency 0.81 USP unit/mg, was a gift from the Endocrinology Study Section of the U.S. National Institutes of Health.
Experimental animals. All the animals used in this study were albino female rats of a local strain, fed ad libitum on a rat-cake diet (Oxoid Diet 86; Oxo Ltd., London S.E.1, U.K.). They were killed by ether anaesthesia. In the growth-hormone experiments, 1 mg of the hormone, dissolved in 0.9% NaCl by adding a trace of alkali, was injected subcutaneously each day over a 5-day period, with a final dose 2-3 h before the animal was killed.
This amount of hormone produced a gain in weight of about 2g/day in a slowly growing female of 200-225g weight, as compared with controls injected with 0.9% NaCl.
RESULTS

Assay methods. (a) Hydroxamate method.
Incubation of the reaction mixture at 370C causes a slight increase in Esoo after treatment with ferric reagent, even in the absence ofglutamate synthetase activity. This is unimportant when measuring the enzyme concentration in active extracts, but it is essential to have an accurate value for the blank extinction when assessing extracts of low or doubtful activity. Investigation showed that the components of the assay mixture that gave rise to most of the non-specificE500 on incubationwerehydroxylamine and mercaptoethanol, and that the presence of the tissue extract, and increase in time of incubation, intensified the extinction. Addition of glutamate in the absence of ATP caused a slight increase in extinction. As a result of these tests, the control reaction was always a mixture from which ATP had been omitted, but to which the tissue extract was added. This was carried through the incubation procedure with the test samples.
(b) NADH method. Some trouble was experienced with a slow oxidation of NADH when the tissue sample was added, but before glutamate was added. The rate of oxidation was roughly proportional to the concentration of ATP present, but varied with different extracts. This artifact was traced to the presence of about 0. 1% of AMP in the ATP that was being used, together with the presence of low and variable amounts of adenylate kinase in the tissue extract. The routine addition of adenylate kinase, in the concentration recommended, with the lactate dehydrogenase and pyruvate kinase, to the reaction mixture, abolished this slow oxidation of NADH without affecting the rate at which ADP was rephosphorylated by pyruvate kinase during the assay.
The method is not specific for glutamine synthetase, which is measured by the increase in the rate of NADH disappearance on the addition of glutamate. With muscle extracts, the rate of NADH oxidation caused by hydrolysis of ATP by adenosine triphosphatase was usually very great before the glutamate was added, and in consequence only small amounts of tissue extract could be added. This largely nullified the increase in sensitivity that could be gained by making measurements on NADH at 340nm; the way in which this interference from adenosine triphosphatases was minimized is described in detail below.
With the NADH method it is possible to use either NH4+ or hydroxylamine as substrate. We found that the activity was greater with NH4+ than with hydroxylamine, (see Table 1 ), and that high concentrations of the latter were slightly inhibitory. However, in the investigations described here it was not possible to use NH4+, since in the presence of the high concentrations of Mg2+ needed to activate pyruvate kinase, the Pi added as an inhibitor formed a copious precipitate of magnesium ammonium phosphate.
With muscle extracts, the activity in dialysed supernatants was found to be the same by the hydroxamate method as by the NADH method.
Optimum conditions for assay. (a) Substrates. The optimum pH range, except for very high Greenberg & Lichtenstein (1959) and Monder (1965) . Apparent Km values for most substrates are quoted by Meister (1962) , but there are some differences of opinion about the optimum concentrations of ATP and Mg2+. To some extent the different estimates of optimum ATP concentration (Speck, 1949a,b; Elliott, 1951 ratio is 0.3. However, Levenbook & Kuhn (1962) and Trush (1963) reported that the activity of glutamine synthetase is inhibited by ATP at concentrations greater than 5mi. We have reinvestigated this question for our own experimental conditions, and since Speck (1949b) , Trush (1963) and Wu (1964) concentration for this concentration of ATP was found to be 15mM (i.e. 5mm-free Mg2+), but in view of the rather higher requirements for full activity of the pyruvate kinase used in the NADH assay method, a concentration of 20mM was in fact used. This is the concentration recommended by Elliott (1951) and Baerle et al. (1957) .
(b) Extraction of enzyme from tissues. Extraction of the frozen and thawed tissue with sodium chloride-sodium bicarbonate solution, as described by Trush (1963) , appeared to give optimum activities. This would be expected from the report by Wu (1963) . In particular, no increase in activity of the extracts was found when homogenization was carried out in the presence of 2.5% sodium deoxycholate or 0.5% sodium dodecyl sulphate, as suggested by Wu (1961) . This is in agreement with the later report by Wu (1963) .
(c) Partial purification of crude extracts. The activity to be expected in muscle and heart extracts was very low (Trush, 1963) . The molar extinction coefficient of ferric glutamylhydroxamate at 500nm is only about 104. This means that the increase in extinction after lOmin of incubation, even with amounts of extract equivalent to 250mg of fresh tissue/tube, was only of the order of 0.1 for skeletal muscle, whereas the extinction ofthe control was about 0.05. For heart the values were even lower. To be certain that the observed increases in extinction were in fact due to glutamine synthetase activity, it was thought desirable to ensure that the amount of hydroxamate produced was proportional (i) to time of incubation and (ii) to the amount of tissue extract added. In addition, Reiner & Hudson (1953) Table 2 . Heart extracts, even after centrifugation and dialysis, did not give any evidence of glutamine synthetase activity that satisfied the two criteria of linearity described above. To eliminate the possibility that purified heart extracts still contained enough of the inhibitor(s) whose existence has been inferred for muscle and kidney extracts, to prevent the detection of small amounts of glutamine synthetase activity, various amounts of heart extracts were added to cuvettes containing suitable amounts of purified rat liver extracts, which were being assayed by the NADH method. The latter contain very little adenosine triphosphatase activity, which makes slight alterations in synthetase activity easier to detect. An experiment in which skeletalmuscle extracts were added to cuvettes containing liver extracts was used as a control.
The effects of both heart and skeletal-muscle extracts on the adenosine triphosphatase activity were completely additive. Skeletal-muscle extract inhibited liver glutamine synthetase by about 10% when added in amounts equivalent to 10mg of fresh muscle. This might be expected from what has already been said about the effect of purification procedures on the activity of these extracts (cf. Fig. 3b ). On the addition ofheart extract containing no detectable activity there was a consistent potentiation of the activity of liver glutamine synthetase by about 25% when extract equivalent to about 10mg of heart was added. The potentiation did not increase when more heart extract was added. In one of the experiments shown in Fig. 5 tor 'constants', calculated from the assumption that the slope or intercept terms of the reciprocal Michaelis-Menten equations were effected by a term 1 + 1/Kg, are given in Table 4 . The inhibition of the kidney enzyme by phosphate was essentially uncompetitive. Inhibition of the muscle enzyme was stronger, with a K, calculated to be approx. 10mM, and the inhibition type was strictly competitive.
Effect of growth hormone. Pituitary growth hormone, either added to the assay systems in vitro, or injected for 5 days into the rats from which the tissues were taken, in amounts sufficient to cause a weight gain of 1-2g/animal per day, did not affect the glutamine synthetase activity, or cause activity to appear in heart-muscle extracts.
1/8 (mm-') Fig. 7 . Double-reciprocal plots for glutamine synthetase in kidney extracts; the NADH assay was used. *, No P,; *, 5mM-PI; V, 20mM-P1. (8) 56.6 (10) 34.8 (10) DISCUSSION We feel confident in asserting that there cannot be more than a trace of glutamine synthetase in rat heart homogenates. It is impossible at this stage to be certain whether the absence of the enzyme is characteristic of all mammalian heart muscle, since the evidence is very conflicting. By direct measurement of enzyme activity, Trush (1963) found a capacity of about 5,umol/h per g in rabbit and cat heart homogenates. However, he also found about the same activity in rat heart homogenates. We have found, in agreement with Reiner & Hudson (1953) , that the activity in high-speed supernatants may be 3-4 times that in homogenates, and Trush's (1963) value for rat heart would therefore be equivalent to 15-20,umol/h per g in our assay conditions. We could hardly have overlooked activity of this order, and indeed we consistently measured this amount of activity in supernatants from muscle homogenates. The results shown in Fig. 5 show that heart-muscle extracts do not contain an inhibitor that might mask glutamine synthetase activity. Wu (1963) failed to find activity not only in rat heart-muscle homogenates, but also in homogenates of skeletal muscle. Doell & Felts (1959) found that labelled glutamine was formed from [14C]glutamate in isolated perfused rabbit heart, although J. Mowbray (personal communication) found that glutamine remained unlabelled in perfused rat heart. Ferdman, Silakova & Trush (1963) found [15N]glutamine, and lsNH3 of higher specific radioactivity, in rabbit hearts 1 h after intraperitoneal injection of [15N]ammonium nitrate, but this is compatible with fairly rapid uptake of glutamine from plasma, as suggested by Ottaway (1969) , together with diffusion of [15N]-ammonia from plasma to intracellular space. Finally, Keul, Doll, Stein, Singer & Reindell (1966) reported that the coronary arterio-venous difference in athletes in training is negative for glutamine and positive for glutamate, implying that glutamine synthesis is occurring in the tissue.
It is at least clear that if there is glutamine synthetase activity in mammalian heart, it is only a fraction of that occurring in avian heart. Activity as great as, or greater than, that found in kidney homogenates has been reported by Gothoskar et al. (1960a) for chicken heart, by Trush (1963) for pigeon heart, and by Wu (1963) for chicken, pigeon and goose heart homogenates. Gothoskar, Raina, Tate & Ramakrishnan (1960b) have pointed out that chick heart cells in tissue culture, unlike rat heart cells, do not require glutamine as a growth factor. It is reasonable to conclude that the glutamine found in rat heart has not been synthesized in that tissue, but almost certainly in the liver (Wu, 1964) .
It follows that the rather high concentration of glutamine in heart cannot be related to the detoxication of ammonia, or to the transport from heart to liver of amino N arising from the catabolism of amino acids. The results of Ottaway (1969) show that there is a steady hydrolysis of glutamine in rat heart, at least in vitro, and there is strong presumptive evidence that the ammonia so formed is removed by reductive synthesis of glutamate. This then undergoes transamination with oxaloacetate and pyruvate, so that amide N of glutamine continuously leaves the heart as the amino N of aspartate and alanine, chiefly the latter. The turnover-time of glutamine in rat heart is about 1 h; this relatively rapid turnover suggests that the maintenance of a constant concentration of glutamine in the heart is important, although the function of the amino acid remains unknown. Table 2 shows that the maximal activity of the enzyme in skeletal muscle is about 20,umol of glutamylhydroxamate formed/h per g of tissue, which is equivalent to about 40,umol of glutamine/h per g (Table 1 ). It is possible that this is an underestimate, since Fig. 3(b) shows that the linear rates of hydroxamate formation over 30min which we used for our estimates of activity in muscle were apparently much lower than the initial rates (during the first 2-5min) with non-dialysed supernatants or homogenates. This was not so with kidney extracts, as shown in Fig. 3(a) . The value of 40,imol/h per g may thus be a minimum estimate, but it is sufficiently high to conclude that the enzyme could be responsible for the formation of the glutamine of muscle. The actual rate of glutamine formation must chiefly depend on the concentration of NH4+ in the tissue, since the concentrations of glutamate and ATP invivo are effectively saturating. The concentration of glutamate dehydrogenase in rat skeletal muscle is low (Wergedal & Harper, 1964) ; thus it seems likely that NH4+ formed intracellularly must be removed by synthesis of glutamine, unless it simply escapes by diffusion.
Our estimates of the glutamine synthetase activity of kidney extracts, with hydroxylamine as a substrate, were slightly higher than those of Reiner & Hudson (1953) , who also used the supernatants from high-speed centrifugation of the homogenates. Both estimates are several times greater than those of Richterich & Goldstein (1958) and Wu (1963) , both of whom used untreated homogenates. The values in Table 2 nevertheless underestimate the true maximal activity of the enzyme, since it can be shown (M. P. Gonzalez, personal communication) that if the ADP is continuously removed in the hydroxamate assay by the addition of phosphoenolpyruvate and pyruvate kinase, the rate ofhydroxamate formation by kidney extracts increases threefold. We place more reliance on the results from the hydroxamate assays, since Gonzalez has also shown that the amount of NADH that disappears in the NADH assay is less than the amount of hydroxamate that appears, suggesting that a side-reaction occurs, possibly the loss of some pyruvate by a transamination.
The chief importance of our kinetic results is the emphasis they throw on the difference between the muscle and kidney enzymes, but some subsidiary points are noteworthy. The inhibition by an excess of Mg2+ shown in Fig. 2 confirms that reported by Speck (1949b) , Trush (1963) and Wu (1964) . In conjunction with the strong inhibition of sheep brain glutamine synthetase by Ca2+, even in the presence of equimolar concentrations of Mg2+, reported by Elliott (1951) , the evidence suggests that Mg2+ is bound to the enzyme and decreases its activity, as well as forming part of the active substrate MgATP2-. A plausible explanation is that MgATP2-binds to the free enzyme, but the product, ADP, leaves the enzyme before the metal ion.
The Michaelis constants for ATP shown in Table 4 , which were derived from studies with the NADH assay method, are about one-tenth of those reported by Speck (1949b) , Elliott (1951) and Pamiljans et al. (1962) . The Km values for ATP that can be derived from the results shown in Fig. 1 are approx. 1 mM, in agreement with the values of the earlier workers, and we conclude that the presence oftraces of ADP in the hydroxamate assay markedly affects some of the rate constants of the enzyme. This effect is distinct from the product inhibition by ADP observed at higher concentrations of the latter (cf. Elliott, 1951) . The difference between the Km values for the muscle and kidney enzyme quoted in Table 4 is significant at the 1% level of probability.
The results of the extensive studies of Meister have been embodied in reaction diagrams (Meister, 1962 (Meister, , 1965 (Meister, , 1968 which imply a kind of TheorellChance mechanism (Cleland, 1963) The results obtained with the muscle enzyme, on the other hand, cannot be accommodated within Meister's (1962) scheme. Competitive inhibition demands that the inhibitor reacts with the form of the enzyme that reacts with the substrate (Cleland, 1963) , and this does not occur in the standard mechanism. Even the addition of a 'deadend' enzyme-Pi complex to the scheme does not help, since it introduces [PI]2 terms into the denominator of the rate equation, whereas the values for Kg in Table 4 are notably independent of the phosphate concentration. 'Partial' inhibition mechanisms ofthe type discussed by Dixon & Webb (1964) give even more complex rate equations and can be excluded from consideration.
A mechanism that would explain our findings is one based on random release of ADP and Pi from the enzyme, as shown in Scheme 1. This mechanism is compatible with competitive inhibition of ATP by ADP, which has been shown for all the mammalian enzymes so far investigated, and which has been established for the chicken heart enzyme (which is known to be inhibited by Pi) by Gothoskar et al (1960a 
which predicts competitive inhibition by phosphate. The mechanism suggested in Scheme 1 can be tested by systematic variation of other reactants and products, and this is now under investigation. The difference in Km for ATP, and in the type of inhibition by Pi, suggest strongly that the enzymes from muscle and kidney are not identical. Other evidence to support this conclusion is the strong inhibition ofthe muscle enzyme by mM-pentachlorophenol, whereas the kidney enzyme is only slightly affected, and the slight difference in the concentrations of ammonium sulphate that will precipitate the enzyme from the supernatant fractions. Some of these differences may be due to interactions between glutamine synthetase and tissue-specific proteins in the extracts, but others cannot be explained on these lines, and it appears that a genuine difference between the two enzymes exists. From the evidence provided by the phosphate-inhibition studies, we surmise that the kidney enzyme is similar to the other mammalian enzymes so far described, and the muscle enzyme is therefore atypical. There are points of resemblance between its properties and those of the enzyme from chicken heart described by Gothoskar et al. (1960a) , but the inhibition of the latter enzyme by phosphate was far more severe than that which we found. All the animal enzymes, including the muscle enzyme, so far described appear to differ considerably from the bacterial enzymes (Kingdon et al. 1968; Liess et al. 1968) . This work was supported by a grant from the Medical Research Council to J. H. 0.
